Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a ground-breaking Griffith University study found...
Striking brain similarities have been detected in patients who experience Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), in particular,...
Unlocking the secrets behind immune exhaustion in ME/CFS and Long COVID patients.
A next-generation COVID-19 mucosal vaccine is set to be a gamechanger not only when delivering the vaccine itself, but also for people who are needle-phobic.
Researchers from Griffith University’s National Centre for Neuroimmunology and Emerging Diseases (NCNED) have made a groundbreaking discovery that could bring...
Researchers find overlap in long COVID and ME/CFS patients using MRI.
People with Long COVID in Australia have poor health outcomes that are comparable with another emerging disease known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Griffith University has entered into a $135 million commercial partnership with Gene Company o further develop a new drug treatment for SARS-CoV-2, the virus responsible for COVID-19.
Griffith University’s research into the potential overlap between Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has received a major boost thanks to a $6.4 million grant from the Stafford Fox Medical Research Foundation.
A video game featuring a mystical character named Rumble has helped Griffith University researchers investigate how school kids fared following lockdown disruption.
